BDX Becton Dickinson & Co stock chart & analysis
Conviction 34HealthcareScan · Fri, Nov 6, 2026Becton Dickinson & Co (BDX) closed at $211.88 (-0.78%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 74, RS Rating 91, -1.4% from its 52-week high, +9.1% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Tue, Jun 30, 2026 · quarterly.
BDX technical analysis
Trend
BDX is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 12.5% above the 50-day ($188.21) and 24.8% above the 200-day ($169.71). ADX(14) at 44 points to a strong, established trend. It meets 5 of 8 trend-template criteria.
Momentum
RSI(14) is 74, in overbought territory. The MACD histogram is positive. Its RS Rating of 91 puts its weighted 12-month performance ahead of about 91% of the US market.
Volume and volatility
Volume on the latest session ran 0.9× its 20-day average. It trades about $369.1M a day on average. ATR(14) is $4.62, 2.2% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.35) shows accumulation.
Key levels
The chart pattern's support is $176.79 and its resistance $200.21. The 52-week range is $140.11 to $214.78; price is 1.4% below the high and 51.2% above the low. The VWAP anchored at the 52-week high is $211.73, below price.
Performance
BDX returned +7.0% (1 week), +15.9% (1 month), +17.9% (3 months), +41.8% (6 months), +20.1% (1 year), +9.1% (year to date).
About Becton Dickinson & Co
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Surgical & Medical Instruments & Apparatus · Listed 1963 · 72,000 employees
Recent news
- BECTON DICKINSON & CO: Earnings resultsSEC EDGAR · Thu, Nov 5, 2026
Congress activity
Disclosed STOCK Act trades in BDX · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 Thomas H. Kean house · R · NJ · traded 2026-05-21 | Sell | $1K–$15K | 2026-05-21 | 2026-06-18 | |
RK Rohit Khanna house · CA | Buy | — | — | 2026-04-07 | |
 Kevin Hern house · OK · traded 2026-03-17 | Sell | $15K–$50K | 2026-03-17 | 2026-03-31 | |
 Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-24 | Sell | $1K–$15K | 2025-06-24 | 2025-08-13 | |
Thomas H. Kean house · R · NJ · traded 2025-05-13 | Buy | $1K–$15K | 2025-05-13 | 2025-06-17 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Buy | $1K–$15K | 2025-05-15 | 2025-06-09 | |
Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-04-28 | |
 Jefferson Shreve house · R · IN · traded 2025-03-05 | Sell | $15K–$50K | 2025-03-05 | 2025-04-11 |
Insider activity
SEC Form 4 transactions in BDX · open-market 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Feld Michael EVP, Chief Revenue Officer · Common Stock · 2026-10-26 | Sell | 76 | $15K | 2026-10-26 | 2026-10-27 |
Feld Michael EVP, Chief Revenue Officer · Common Stock · 2026-09-28 | Sell | 76 | $14K | 2026-09-28 | 2026-09-29 |
Feld Michael EVP, Chief Revenue Officer · Common Stock · 2026-08-26 | Sell | 165 | $31K | 2026-08-26 | 2026-08-27 |
Feld Michael EVP, Chief Revenue Officer · Common Stock · 2026-08-20 | Tax | 1.05K | — | 2026-08-20 | 2026-08-24 |
Polen Thomas E Jr Chairman, CEO and President · Common Stock · 2026-08-13 | Exercise | 43.28K | $7.2M | 2026-08-13 | 2026-08-14 |
Polen Thomas E Jr Chairman, CEO and President · Common Stock · 2026-08-13 | Disposition | 39.13K | $7.2M | 2026-08-13 | 2026-08-14 |
Polen Thomas E Jr Chairman, CEO and President · Common Stock · 2026-08-13 | Sell | 4.15K | $768K | 2026-08-13 | 2026-08-14 |
Polen Thomas E Jr Chairman, CEO and President · Stock Appreciation Rights · 2026-08-13 | Exercise | 43.28K | — | 2026-08-13 | 2026-08-14 |
Goette Roland EVP and President, EMEA · Common Stock · 2026-08-11 | Sell | 2.44K | $441K | 2026-08-11 | 2026-08-12 |
Byington Carrie L Director · Rights to Common Stock Under BD Deferred Compensation Plan · 2026-08-06 | Grant | 94 | $16K | 2026-08-06 | 2026-08-06 |
SEC filings
EDGAR filings in BDX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.